Translate this page into:
Short Communication
Oral acyclovir in recurrent genital herpes
RK Pandhi, Asit Mittal, Lalit Gupta
,
Correspondence Address:
R K Pandhi
Correspondence Address:
R K Pandhi
| How to cite this article: Pandhi R K, Mittal A, Gupta L. Oral acyclovir in recurrent genital herpes. Indian J Dermatol Venereol Leprol 1993;59:71-73 |
Copyright: (C)1993 Indian Journal of Dermatology, Venereology, and Leprology
Abstract
Recurrent genital herpes (RGH) is a difficult condition to treat. Oral acyclovir therapy has been shown to have a definite role in suppressing the recurrent episodes of the disease. Most studies, however, are available from the West. We report our experience with oral acyclovir therapy. Ten patients of RGH with more than 8 episodes/year received acylovir in the dose of 200 mg thrice daily for 6 months. They were followed up for a period ranging from 6 months to 3.5 years. Eight patients stayed symptom-free while on therapy and during the follow-up period. One patient showed a recurrence while on treatment and another 4 months after stopping treatment. No adverse effects were seen in any of the patients.
Keywords: Acyclovir, Genital Herpes
Fulltext Views
2,031
PDF downloads
385
